ECB Rate Path May Deepen Stagflation Risks Berenberg Economist Warns Beyond Meat Reports First Quarter Financial Results Market Awaits Sector Cues Bitcoin Slips Below 77000 as US Military Strikes on Iran and ETF Outflows Weigh on Sentiment Thailands Line Man Diversifies Beyond Food Delivery Targets 2027 IPO Trump Urges Supreme Court to Halt TikTok Ban What It Means for Investors Powell Vows No Shadow Chair Role but Warsh Tensions Loom as Fed Meets with Former Chair PAPL Q3 2025 Earnings EPS Surprises to the Upside Despite Stock Decline PRIM Q1 2026 Earnings EPS Misses Estimates by Over 31 Stock Edges Higher IBEX Q1 2026 Earnings EPS Beats Estimates Stock Slips Slightly Centene CNC Q1 2026 Earnings Massive EPS Beat Shocks Estimates Stock Rises 237 AZZ Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Frontdoor Inc FTDR Q1 2026 Earnings EPS Surprises to the Upside Amid Steady Operations BrightSpring Health Services BTSGU Holds Steady at 19406 as Tangible Equity Unit Trades in Tight Range X4 Pharmaceuticals XFOR Holds Steady at 404 as Traders Await News Catalyst General Purpose Acquisition Corp Warrant GPACW Holds Steady at 028 Despite Low Volume Eaton Vance Short Duration Income Fund EVG Holds Steady Near Key Support After Slight Decline Community Healthcare Trust CHCT Slides 19 Amid Ongoing Sector Headwinds Kohls Sales Beat Expectations Can New Strategies Revive the Retailer OBDC Q1 2026 Earnings EPS Misses Estimates Amidst Challenging Environment OUTFRONT Media OUT Edges Higher as Support Holds Firm KB Financial Group Q4 2025 Earnings Strong EPS Beat Offsets Modest Stock Decline REVB Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Challenges TOWN Q1 2026 Earnings EPS Misses Estimates Amid Persistent Margin Headwinds BWA Q1 2026 Earnings EPS Surprise Drives Positive Market Reaction Fortune Brands Innovations FBIN Q1 2026 Earnings EPS Falls Just Short of Estimates Despite Strong Stock Reaction TRMB Q1 2026 Earnings EPS Surpasses Estimates by 79 Amid Strong Operational Execution Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surprises to the Upside as Stock Dips